Trade with Eva: Analytics in action >>

Saturday, September 24, 2022

This week's biggest % winners & losers : Sep 19 - 23, 22 (wk 38)

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers
  • Healthcare: CO (2.99 +22.95%), ALLK (5.27 +14.96%), BEAT (2.03 +6.23%), PRTA (30.73 +4.38%)
  • Materials: GGB (4.62 +5.24%)
  • Consumer Discretionary: MOGU (2.26 +7.09%)
  • Financials: HYT (8.67 +15.6%), SQQQ (56.3 +14.62%), BBD (3.82 +6.56%), ITUB (5.36 +6.14%)
  • Energy: PBF (29.81 +5.21%)
  • Consumer Staples: FRPT (45.59 +11.74%), CALM (60.51 +6.44%), GIS (79.17 +5.21%)
  • Utilities: CIG (2.3 +4.32%), EBR (8.81 +4.2%)
This week's top % losers
  • Healthcare: CASI (2.65 -37.5%), NVAX (20.99 -30.98%), GRTS (2.66 -24.57%), ALLO (10.48 -23.37%), ADAP (1.18 -23.2%), NVTA (2.45 -22.96%)
  • Industrials: MRC (7.22 -23.79%)
  • Information Technology: AAOI (2.84 -24.6%), AVYA (1.43 -24.07%), TWOU (5.8 -22.67%)
  • Energy: TELL (2.38 -39.75%), BPT (11.51 -24.57%), NBR (94.32 -24.3%), KOS (4.98 -23.6%), PTEN (10.77 -22.96%)

Monday, September 12, 2022

Rent the Runway (RENT) reported earnings on Mon 12 Sep 22 (a/h)

  •  Fashion rental service CEO says roughly 20% of business is from shoppers seeking work clothes, a much smaller percentage than before pandemic

Rent the Runway Inc. (RENT) said it would reduce its corporate workforce by 24%, primarily through layoffs, as the fashion-rental service adjusts to a slowdown in consumer spending and shifts from shopping habits adopted earlier in the pandemic.

The New York company on Monday didn’t specify the total number of jobs affected. It had 958 full-time employees and 138 part-time employees as of Jan. 31, according to securities filings.

The workforce reduction is meant to transform Rent the Runway from a cash burner into a company that can fund itself through revenue alone, co-founder and Chief Executive Jenn Hyman said in an interview. Rent the Runway was founded in November 2008 and since its inception it has incurred roughly $878 million of losses as of July.

The announcement came as the company reported that despite revenue rising 64% in the second quarter from a year earlier, its active subscriber count unexpectedly dropped from the first quarter.

It ended the July quarter with 124,131 active subscribers, representing an increase of 27% from a year ago, but lower than the nearly 135,000 reported for the first quarter.

Friday, September 9, 2022

NeoVolta (NEOV) to be deployed in EOS Linx EV charging stations at select national gas locations

  • Co announced that its systems will be deployed in electric vehicle charging stations at select national gas and convenience store locations, starting in Georgia.
  • This initial phase of installations is part of an expected nationwide rollout of NeoVolta batteries in 1,000 EOS Linx EV charging stations at various gas stations, convenience stores, and hotel chains across the country.

Thursday, September 8, 2022

===Amylyx Pharmaceuticals (AMLX) announces FDA Advisory Committee supports approval of AMX0035 for the treatment of ALS


Amylyx Pharmaceuticals announces FDA Advisory Committee supports approval of AMX0035 for the treatment of ALS 
  • Co announced the FDA Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) voted (7 yes votes and 2 no votes) that the available evidence of effectiveness is sufficient to support approval of AMX0035 (sodium phenylbutyrate and taurursodiol [also known as ursodoxicoltaurine]) for the treatment of amyotrophic lateral sclerosis (ALS).
  • The PCNSDAC's decision was based on a review of all available evidence, including new analyses submitted for discussion at the September 7 meeting and the information presented at the March 30, 2022, PCNS meeting.
  • The PCNSDAC recommendations, while not binding, will be considered by the FDA in its review of the pending New Drug Application (NDA) for AMX0035. As previously reported, the Prescription Drug User Fee Act target action date for the NDA is September 29, 2022, which was extended by the FDA to allow more time to review additional analyses of data from the Company's clinical studies.

Wednesday, September 7, 2022

==Asana (ASAN) reported earnings on Wed 7 Sep 22 (a/h)


Asana beats by $0.05, beats on revs; guides Q3 EPS in-line, revs above consensus; guides FY23 revs above consensus; expects to reach free cash flow positive before the end of CY24 
  • Reports Q2 (Jul) loss of $(0.34) per share, excluding non-recurring items, $0.05 better than the S&P Capital IQ Consensus of $(0.39); revenues rose 50.8% year/year to $134.9 mln vs the $127.27 mln S&P Capital IQ Consensus.
    • The number of customers spending $100,000 or more on an annualized basis in Q2 grew to 462, an increase of 105% year over year.
  • Co issues guidance for Q3, sees EPS of $(0.33)-$(0.32), excluding non-recurring items, vs. $(0.32) S&P Capital IQ Consensus; sees Q3 revs of $138.5-139.5 mln vs. $137.83 mln S&P Capital IQ Consensus.
  • Co issues upside guidance for FY23, sees FY23 revs of $544-547 mln vs. $535.47 mln S&P Capital IQ Consensus.
  • Co also announced $350 mln private placement.
  • Co added, "We believe we are fully-funded to execute on our current strategies and well-positioned to reach free cash flow positive before the end of calendar 2024."